IFP Advisors Inc raised its stake in shares of SPDR S&P Biotech (NYSEARCA:XBI) by 5.1% during the second quarter, Holdings Channel reports. The firm owned 10,213 shares of the exchange traded fund’s stock after buying an additional 496 shares during the period. IFP Advisors Inc’s holdings in SPDR S&P Biotech were worth $788,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Rand Wealth LLC increased its position in SPDR S&P Biotech by 1.8% in the second quarter. Rand Wealth LLC now owns 49,147 shares of the exchange traded fund’s stock valued at $3,793,000 after buying an additional 863 shares during the period. Telemus Capital LLC acquired a new position in SPDR S&P Biotech during the second quarter valued at approximately $232,000. Stratos Wealth Partners LTD. increased its position in SPDR S&P Biotech by 39.6% in the second quarter. Stratos Wealth Partners LTD. now owns 11,528 shares of the exchange traded fund’s stock valued at $890,000 after buying an additional 3,269 shares during the period. Papp L Roy & Associates increased its position in SPDR S&P Biotech by 3.1% in the second quarter. Papp L Roy & Associates now owns 187,538 shares of the exchange traded fund’s stock valued at $14,474,000 after buying an additional 5,648 shares during the period. Finally, Weatherly Asset Management L. P. increased its position in SPDR S&P Biotech by 4.5% in the second quarter. Weatherly Asset Management L. P. now owns 125,537 shares of the exchange traded fund’s stock valued at $9,689,000 after buying an additional 5,374 shares during the period.

SPDR S&P Biotech (XBI) opened at 74.47 on Friday. The company has a 50 day moving average of $78.58 and a 200 day moving average of $71.46. SPDR S&P Biotech has a 1-year low of $53.15 and a 1-year high of $82.38.

TRADEMARK VIOLATION NOTICE: “IFP Advisors Inc Increases Position in SPDR S&P Biotech (NYSEARCA:XBI)” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/ifp-advisors-inc-increases-position-in-spdr-sp-biotech-nysearcaxbi/1472932.html.

SPDR S&P Biotech Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with Analyst Ratings Network's FREE daily email newsletter.